# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Michelangelo Buonarroti (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE002-SYN-TD
- Date: 1560-04-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Serena Castellano, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week hand osteoarthritis review after stopping ibuprofen; rheumatology consultation today. **S**

## History of present illness

Mr. Buonarroti returns four weeks after stopping over-the-counter ibuprofen 1200 mg a day and starting diclofenac gel four times daily, acetaminophen as needed, and a left thumb-base splint. He uses the gel faithfully and takes acetaminophen 1 g about twice a day. His hand pain is somewhat better, about 5 of 10, but gripping a chisel for more than an hour still brings on a deep ache at the base of the left thumb, and morning stiffness lasts about 15 minutes. He wears the splint for carving and at night. He has not yet started hand therapy because of a waiting list. He has had no gout flare, urinary symptoms, rash, or stomach upset. He saw the rheumatologist this morning and had the thumb-base injection. **S**

| Element | Detail |
|---|---|
| Pain | About 5 of 10, worst at the left thumb base after an hour of carving |
| Stiffness | About 15 minutes in the morning |
| Treatment use | Diclofenac gel four times daily; acetaminophen 1 g about twice a day; splint for carving and at night |
| Ibuprofen | None since the last visit |
| Hand therapy | Not started; on a waiting list |
| Gout and stones | No flare; no urinary symptoms |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Left thumb-base ache with use; brief morning stiffness; no joint swelling elsewhere; no foot pain |
| Integumentary | Negative | No rash where the gel is applied |
| Gastrointestinal | Negative | No indigestion or dark stools |
| Genitourinary | Negative | No flank pain or blood in the urine |

4 systems reviewed. **S**

## Current medications

- Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily **S**
- Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either hand **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/78 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 61.8 kg; BMI 21.9 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.5 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 20 mg/dL; Creatinine: 1.02 mg/dL; eGFR: 72 mL/min/1.73 m²; Glucose: 90 mg/dL; Hand pain (0-10 numeric rating): 5; PROMIS upper extremity T-score: 37; Grip strength, left hand: 15 kg; Grip strength, right hand: 22 kg. All results are synthetic.

## Change since baseline

- Sodium: 138 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 4.9 mmol/L at baseline, 4.5 mmol/L at this visit **S**
- Bicarbonate (total CO2): 24 mmol/L at baseline, 25 mmol/L at this visit **S**
- BUN: 26 mg/dL (high) at baseline, 20 mg/dL at this visit **S**
- Creatinine: 1.21 mg/dL at baseline, 1.02 mg/dL at this visit **S**
- eGFR: 59 mL/min/1.73 m² (low) at baseline, 72 mL/min/1.73 m² at this visit **S**
- Glucose: 92 mg/dL at baseline, 90 mg/dL at this visit **S**
- Hand pain (0-10 numeric rating): 7 at baseline, 5 at this visit **S**
- PROMIS upper extremity T-score: 33 at baseline, 37 at this visit **S**
- Grip strength, left hand: 14 kg at baseline, 15 kg at this visit **S**
- Grip strength, right hand: 22 kg at baseline, 22 kg at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well, wiry, and impatient to get back to work |
| Left hand | Squaring and tenderness at the first carpometacarpal joint with a positive grind test; bony enlargement of the thumb metacarpophalangeal and interphalangeal and the index metacarpophalangeal and proximal interphalangeal joints; no warmth or soft swelling; thumb abduction reduced |
| Right hand | Heberden nodes of the index and middle fingers; no synovitis |
| Feet | No tophi, warmth, or swelling |
| Cardiovascular | Regular rhythm |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Left hand osteoarthritis** (M19.042). Pain 5 of 10, down from 7; PROMIS upper extremity T-score 37, up from 33; grip unchanged. Rheumatology agrees with nodal, non-erosive osteoarthritis, finds no inflammatory or crystal arthritis, and injected the left thumb base today. **S**
   - Continue diclofenac gel, the splint, and acetaminophen up to 3 g a day.
   - No carving with the left hand for 48 hours after the injection.
   - Hand therapy waiting list escalated; home exercise sheet given today.
   - Review pain and function four to six weeks after the injection.
2. **Right hand osteoarthritis** (M19.041). Mild nodal disease; little pain. **S**
   - Gel as needed.
3. **Gout** (M1A.9XX0). No flare since stopping ibuprofen; urate 5.4 mg/dL last month on allopurinol 200 mg, which suits his kidney function. **S**
   - Continue allopurinol; serum urate every six months.
4. **History of urinary stones** (Z87.442). No symptoms; drinks about 2 L of water a day. **S**
   - Continue fluids.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Hand pain, 0 to 10 numeric rating | Each clinical encounter; after each therapeutic trial | Completed today | 5 of 10, down from 7 |
| Survey | Validated function measure (PROMIS upper extremity T-score; AUSCAN and FIHOA have no LOINC code) | Each clinical encounter | Completed today | T-score 37 (population mean 50; higher is better) |
| Examination | Grip strength by dynamometer | Each clinical encounter in this plan | Completed today | Left 15 kg, right 22 kg |
| Examination | Joint examination: range of motion, swelling, alignment, crepitus | Each clinical encounter | Completed today | No synovitis; thumb-base grind positive; reduced thumb abduction |
| Laboratory | Creatinine, potassium, and blood pressure after stopping a chronic oral NSAID | Periodically on chronic oral NSAIDs; recheck after stopping when kidney function fell | Completed today | Creatinine 1.02 mg/dL (eGFR 72), down from 1.21 (eGFR 59) on ibuprofen; potassium 4.5 mmol/L; blood pressure 134/78, down from 148/82 |
| Medication safety | Oral NSAID avoidance and topical NSAID use | Each clinical encounter | Completed today | No ibuprofen; diclofenac gel about 8 g a day, within the limit for the hands |
| Medication safety | Acetaminophen dose | Each clinical encounter while used regularly | Completed today | About 2 g a day, under the 3 g limit |
| Laboratory | ALT on regular acetaminophen | Periodically, especially near 3 g a day | Up to date | ALT 18 U/L last month; recheck in about six months |
| Referral | Occupational hand therapy | At diagnosis, as part of first-line care | Deferred | Requested at intake and not started four weeks later because of a waiting list, a delay in the protocol's first-line care. No harm so far: pain and function are improving. Corrective action: request escalated and a home exercise sheet given today |
| Referral | Rheumatology consultation | When the diagnosis is uncertain or before an injection | Completed today | Seen today; thumb-base glucocorticoid injection given |
| Imaging | Hand radiographs | At diagnosis if uncertain; not for routine follow-up | Not indicated | Baseline films last month; no repeat imaging |
| Self-management | Exercise, joint protection, and splint use | Each clinical encounter | Completed today | Splint for carving and at night; home exercises begun today |
| Laboratory | Serum urate | Every 6 months at target | Up to date | 5.4 mg/dL last month |
| Self-management | Fluid intake for stone prevention | Each clinical encounter | Completed today | About 2 L of water a day |

## Goal progress

- Hand pain at or below 3 of 10 on most days by the seven-month review. In progress; target 1560-10-19. **S**
- Carve for at least three hours a morning and write his own letters. In progress; target 1560-10-19. **S**
- No oral NSAID use and creatinine back to his baseline. Outcome by 1560-04-13: Ibuprofen stopped; creatinine from 1.21 to 1.02 mg/dL. **S**
- Serum urate below 6 mg/dL and no gout flare or stone. In progress; target 1560-10-19. **S**
- No falls, with safe ladder and scaffold use. In progress; target 1560-10-19. **S**

## Guideline basis

- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Rheumatol 2020;72(2):220-233)
- 2020 American College of Rheumatology Guideline for the Management of Gout (2020), American College of Rheumatology (Arthritis Care Res 2020;72(6):744-760)
- Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019), American Urological Association
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (J Am Geriatr Soc 2023;71(7):2052-2081)
- CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis monograph (2026), Aether Forge

## Follow-up

- Telephone check one week after the injection. Hand review with pain and function scores four to six weeks after the injection, then at about three months. **S**
- Next scheduled visit 1560-07-13: hand osteoarthritis review three months after a thumb-base injection. **S**
